Remove Pharmaceutical Industry Remove Public Health Remove World Health
article thumbnail

COVID-19 Showcased Failed Global Cooperation

Bill of Health

By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the World Health Organization officially declared the “emergency” phase of the COVID-19 pandemic over. Public health emergencies aren’t entirely preventable. Solidarity operates at two intersecting levels.

COVID-19 303
article thumbnail

The Case for Procurement Transparency

Bill of Health

By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. States can no longer pretend not to know this.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

Importantly, most of the commitments made under the Open COVID Pledge were designed to expire at the end of the COVID-19 pandemic as determined by the World Health Organization (WHO) or January 1, 2023, whichever occurs first (the 2023 date is now in the process of being extended). Moderna’s Pledge. From 2020 to 2022, the U.S.

article thumbnail

Unseen Scars: The Devastating Impact of Corruption on Mental Health Systems in Low and Middle-Income Countries

Bill of Health

by Daniela Cepeda Cuadrado There is a wealth of research demonstrating that corruption — the abuse of entrusted power for private gain — has contributed to weakening health systems and worsening public health globally. Yet, funding for mental health is grossly inadequate. The industry gave more than $14.2

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

It provides a practical guide for the pharmaceutical industry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines. Schedule 10 lists substances of such danger to public health as to warrant their prohibition from supply and use.

FDA 52